First-In-Human HER2-targeted Imaging Using89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients With Breast Cancer

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.117.202010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

Molecular Imaging With Positron Emission Tomography and Computed Tomography (PET/CT) for Selecting First-Line Targeted Treatment in Metastatic Breast Cancer: A Cost-Effectiveness Study

Oncotarget
Oncology
2018English

First-In-Human uPAR PET: Imaging of Cancer Aggressiveness

Theranostics
MedicineToxicologyPharmaceuticsPharmacology
2015English

Estimated Life-Years Saved in Women With HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

68Ga-Nota-Prgd2 PET/CT for Integrin Imaging in Patients With Lung Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Pcn89 - Cost –Effectiveness Analysis of Pertuzumab as First Line Neoadjuvant Treatment Option for Patients Her2 + Breast Cancer in Republic of Macedonia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Quantitative Tumor Perfusion Imaging With 82Rubidium-Pet/Ct in Prostate Cancer – Analytical and Clinical Validation

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2019English

Pharmacokinetic and Exploratory Exposure–response Analysis of Pertuzumab in Patients With Operable HER2-positive Early Breast Cancer in the APHINITY Study

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2019English

Patient With Metastatic Breast Cancer, HER2-positive, Trastuzumab- And Pertuzumab-Resistant Responding to Lapatinib

AboutOpen
2018English

Pertuzumab in Human Epidermal Growth-Factor Receptor 2-Positive Breast Cancer: Clinical and Economic Considerations

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy